MarketResearch.biz announces publication of its most recently generated research report titled, “Global Interventional Cardiology Devices Market by Product Type (Stents, Balloon, Catheters, Cutting Balloon, Guidewires, Guide Catheters, Angiographic Catheters, Intravascular Ultrasound Imaging System, Atherectomy Devices, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Global Forecast to 2027.”, which offers a holistic view of the interventional cardiology devices market through systematic segmentation that covers every aspect of the target market.
Interventional cardiology is a specialty area within the larger field of cardiology. Interventional cardiology is a branch of cardiology that deals specifically with catheter-based treatment of structural heart diseases. Interventional cardiology devices are equipment that is used for carrying out surgical processes of heart.
Browse the full “Interventional Cardiology Devices Market By Product Type (Stents, Balloon, Catheters, Cutting Balloon, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Specialty Clinics), and Region – Global Forecast to 2028” report at https://marketresearch.biz/report/interventional-cardiology-devices-market/
Global Interventional Cardiology Devices Market: Dynamics
Increasing incidence of cardiovascular diseases across the globe is a major factor expected to drive the growth of the global interventional cardiology devices market. In addition, increasing geriatric population across the globe, increasing government expenditure for development of healthcare infrastructure, availability of favorable reimbursement policies across various countries in the developed regions such as US, Canada, UK, and certain developing countries of Asia Pacific are some of the factors expected to drive the growth of the target market.
The high manufacturing cost of medical devices, coupled with the availability of cost-effective devices offered by domestic players is resulting in increasing pressure on major players to cut down prices of devices and is a factor expected to restraint the growth of the target market to a significant extent.
Prominent players are focused on adopting extensive expansion through merger and acquisition, collaboration activities in order to enhance product portfolio as well as expand its geographical footprint. For instance, in 2017, Abbott Laboratories received CE Mark for XIENCE Sierra, everolimus-eluting coronary stent system. The objective of this is to strengthen its product portfolio and expand its business in Europe. The aforementioned is a key trend witnessed in the target market currently.
Global Interventional Cardiology Devices Market: Market Forecast
The comprehensive research report comprises a complete forecast of the global interventional cardiology devices market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global interventional cardiology devices market is expected to expand at a CAGR of over 6.6% over the forecast period.
Global Interventional Cardiology Devices Market: Segmental Snapshot
The market report has been segmented on the basis of product type, end user, and region. The product type segments include stents, balloon catheters, cutting balloon, guidewires, guide catheters, angiographic catheters, intravascular ultrasound imaging system, atherectomy devices, and others. The end user segments include hospitals, ambulatory surgical centers, and specialty clinics. The regions covered in the analysis include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
By Product Type: The stents purifier segment is expected to account for highest revenue share contribution as compared to other product type segments, and is expected to register highest CAGR of over 6.7% over the forecast period
By End User: The hospital’s segment is projected to account for highest revenue share as compared to that of other end user segments, and projected to register highest CAGR of over 6.7% over the forecast period
By Region: The market in North America accounted for the highest revenue share in the global interventional cardiology devices market. The market in the Asia Pacific is projected to register the highest CAGR of over 7% during the forecast period.
Global Interventional Cardiology Devices Market: Competitive Analysis
The research report on the global interventional cardiology devices market include profiles of some of major companies such as Cardinal Health, Inc., Blue Sail Medical Co., Ltd. (Biosensors International Group, Ltd.), Abbott Laboratories, Medtronic plc, B. Braun Melsungen AG, Boston Scientific Corporation, Terumo Corporation, Koninklijke Philips N.V., Cardiovascular Systems, Inc., and Johnson & Johnson
The Global Interventional Cardiology Devices Market: Industry, Size, Share, Growth, Trends, and Forecast, 2018–2027 report has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global Interventional Cardiology Devices Market for 2017–2027.
MarketResearch.biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. MarketResearch.biz offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.
Like us on Facebook: https://www.facebook.com/marketresearch.biz
Follow on Twitter+: https://twitter.com/PrudourResearch
420 Lexington Avenue, Suite 300
New York City, NY 10170,
Email ID: [email protected]